Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134755) titled 'Application Effects of Different Doses of Remimazolam Besylate in Painless Gastroscopy in Morbidly Obese Patients: A Prospective, Single-Center, Double-Blind, Randomized Controlled Trial' on Oct. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Affiliated Hospital of Zunyi Medical University
Condition:
Morbidly obese patients requiring painless gastroscopy
Intervention:
Group A:Different doses of remimazolam besylate
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-29
Target Sample Size: Group A:45;Group B:45;
Countries of Recruitment:
China
...